The US FDA approved Merck’s cholesterol-lowering pill, it said on Thursday, the first in a class of drugs dominated by ...

The FDA has accepted Apnimed’s NDA for AD109 (aroxybutynin/atomoxetine), a potential first-in-class oral therapy for adults with obstructive sleep apnea.

Researchers from DANDRITE have played a central role in developing a new oral treatment that, for the first time ever, has shown promising results in a clinical trial involving patients—a breakthrough ...

For years, treatment of older patients with acute myeloid leukemia—an aggressive cancer of the blood and bone marrow—has required injections administered in a clinic for five to seven consecutive days ...

CNBC’s “Fast Money” team is joined by Nello Mainolfi, founder, president and CEO of Kymera Therapeutics, to discuss the ...

What Is It, and Why Does It Matter? Utebzi (tebipenem pivoxil) is an oral carbapenem antibiotic. It blocks proteins that bacteria use to build their cell walls, which stops them from growing, allowing ...

What Is Hyrnuo, and Why Does It Matter? Hyrnuo (sevabertinib) is a new oral medicine for adults with advanced nonsquamous non-small-cell lung cancer (NSCLC) carrying a specific genetic change known as ...

Doctors classify oral cancer using stages 0–4, with higher numbers meaning more advanced disease. Treatments and outlooks can vary considerably in the later stages. Doctors determine the stage of oral ...

Oral cancer may recur where it initially started or elsewhere in the body. The recurrence rates differ for people with early and advanced stages of oral cancer. Oral cancer can occur anywhere in the ...